Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD.
The item "Diluted-EPS" stands at 8.63 United States Dollars for the trailing twelve months (TTM) period ending 06/30/2026, the lowest value since 03/31/2025.
Johnson & Johnson's second quarter result of 2.27 USD for the item "Diluted EPS" represents an increase of 5.93 percent compared to it's first quarter result.
Also, Johnson & Johnson's second quarter result of 2.27 USD for the item "Diluted EPS" represents a decrease of -0.91 percent compared to it's second quarter result of last year.
Looking again at the trailing twelve months series (TTM), Johnson & Johnson's second quarter result of 8.63 USD for the item "Diluted EPS" represents a decrease of -0.24 percent compared to it's first quarter result.
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -7.72 percent compared to the value the year prior.
The 1 year change in percent is -7.72.
The 3 year change in percent is 75.02.
The 5 year change in percent is 29.72.
The 10 year change in percent is 62.52.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Diluted EPS | 905,699,262,464.00 |
![]() | AbbVie Inc - Diluted EPS | 399,570,305,024.00 |
![]() | Roche Holding AG - Diluted EPS | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Diluted EPS | 280,205,508,085.11 |
![]() | Novartis AG - Diluted EPS | 255,096,620,580.91 |